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ABSTRACT We report a direct technique for determining the
binding sites of small molecules on naturally occurring heteroge-
neous DNA. Methidiumpropyl-EDTAFe(II) [MPE-Fe(II)] cleaves
double helical DNA with low sequence specificity. Using a com-
bination of MPE-Fe(H) cleavage of drug-protected DNA frag-
ments and Maxam-Gilbert gel methods of sequence analysis, we
have determined the preferred binding sites on a Rsa I-EcoRI
restriction fragment from pBR322 for the intercalator actinomycin
D and the minor groove binders netropsin and distamycin A. Ne-
tropsin and distamycin A gave identical DNA cleavage-inhibition
patterns and bound preferentially to A+T-rich regions with a
minimal protected site of four base pairs. We were able to observe
the effect ofincreasing concentration on site selection by netropsin
and distamycin A. Actinomycin D afforded a completely different
cleavage-inhibition pattern, with 4- to 16-base-pair-long protected
regions centered around one or more G-C base pairs.
Many small molecules important in antibiotic chemotherapy
bind to double helical DNA (1). Although it is possible to de-
termine the overall affinity and stoichiometry of the noncova-
lent binding of drugs to DNA, the exact locations and extent of
preferred binding sites on naturally occurring heterogeneous
DNA sequences are not known. In the case of protein-DNA
binding specificity, one useful method for determining protein
binding sites on DNA is the DNase inhibition pattern tech-
nique, which combines DNase cleavage of protein-protected
DNA fragments and Maxam-Gilbert sequence determination
methods (2, 3). This useful technique relies on the relatively low
specificity of DNase I in a partial digestion and the ability of
DNA-bound protein to prevent cleavage of the DNA backbone
between the base pairs it covers. The protein-protected DNA
sequence is expressed as a gap (light region) in the usually uni-
form ladder seen in the autoradiogram from a sequence analysis
gel revealing the position and extent of the protein binding site
(2, 3). This technique has not yet been reported to be useful for
small molecules such as drugs important in chemotherapy.
The simple bifunctional molecule, methidiumpropyl-EDTA
(MPE) contains the DNA intercalator methidium covalently
bound by a short hydrocarbon tether to the metal chelator
EDTA (4) (Fig. 1). MPE in the presence of ferrous ion and ox-
ygen efficiently produces single-strand breaks in double helical
DNA (4). Using 3' end-labeled DNA restriction fragments from
pBR322 plasmid, we have found that MPE is a relatively non-
sequence-specific DNA cleaving agent. In effect, MPE-Fe(II)
is a small synthetic scissor for DNA that mimics the behavior
of DNase and, because of its size, might be a useful tool for
probing the locations and extent of binding sites of drugs on
naturally occurring DNA.
Actinomycin D, an antitumor antibiotic containing a phen-
oxazone chromaphore and two pentapeptide rings, binds dou-
ble helical DNA (1). Solution studies are consistent with inter-
calation as a mode of binding and reveal a preference for
guanine-pyrimidine sequences (1, 5-9). Crystallographic stud-
ies have provided some insight into the nature of the specific
guanine-actinomycin interaction (10, 11).
The antibiotics netropsin and distamycin A are basic oligo-
peptides containing two and three N-methylpyrrole rings, re-
spectively. Netropsin and distamycin A appear to bind in the
minor groove of double helical DNA. From solution studies
with synthetic polynucleotides, a strong preference for A+T-
rich polymers has been shown (12-14). The specificity of dis-
tamycin/netropsin binding presumably results from hydrogen
bonding between the N-H of the amide linkages of the anti-
biotic and the potential H-bond acceptor substituents on the
A-T base pairs, such as 0-2 of thymine and N-3 of adenine (1,
12-16) (Fig. 2).
We report here a direct technique that combines MPEFe(II)
treatment ofdrug-protected DNA fragments and Maxam-Gilbert
sequence analysis methods to determine the preferred binding
sites for the intercalator actinomycin and the minor groove
binders netropsin and distamycin A on naturally occurring het-
erogeneous segments of double helical DNA (Fig. 3). For com-
parison, the well-characterized anthracycline antitumor anti-
biotic daunomycin, an intercalator without firm evidence for
base composition specificity, was included in this study (1,
17-19).
MATERIALS AND METHODS
Actinomycin D was obtained from Merck, Sharpe & Dohme.
Daunomycin and dithiothreitol were obtained from Calbio-
chem. Distamycin A was obtained from Boehringer Mann-
heim. Netropsin was a gift from D. Patel. MPE was synthesized
and purified by procedures as described (4). Fe(NH4)2(SO4)2'
6H20 was obtained from Baker.
Solutions of Fe(NH4)2(SO4)2, dithiothreitol, and MPE were
prepared freshly. MPE was characterized spectroscopically be-
fore use. Each reaction mixture (final volume, 10 A1l) contained
10 mM Tris'HCl (pH 7.8), 50mM NaCl, and -600 cpm of end-
labeled [32P]DNA, with the final DNA concentration made up
to 100 AM (base pairs) by the addition of sonicated calf thymus
DNA. When present, the final MPE concentration was 10 ,uM;
Fe(II), 10 ,AM; and dithiothreitol, 4 mM. Drug concentrations
were adjusted as specified in the legend to Fig. 4. A solution
of buffered DNA was incubated for 30 min at 20°C with the in-
hibition drug (either actinomycin D, daunomycin, distamycin,
or netropsin). The reaction was initiated by the addition of
Abbreviation: MPE, methidiumpropyl-EDTA.
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FIG. 1. MPE-Fe(II).
MPE-Fe(II) and dithiothreitol in this order. The reaction was
allowed to run at 37C for 10 min, stopped by freezing in dry
ice, Iyophilized, and resuspended in formamide loading buffer
for gel electrophoresis (20).
Preparation of Specific Labeled DNA Fragments. DNA for
this investigation was isolated from the bacterial plasmid
pBR322 whose entire sequence is known (21). Milligram quan-
tities of the plasmid were grown in Escherichia coli, strain HB
101, and isolated by procedures similar to those of Tanaka and
Weisblum (22). Superhelical pBR322 plasmids were first di-
gested with the restriction endonuclease EcoRI and then 3'
end-labeled with [32P]dATPs and the Klenow fragment ofDNA
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FIG. 2. Antibiotics used to bind to DNA and inhibit cleavage by
MPE.
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FIG. 3. Illustration of MPE cleavage technique with Maxam-
Gilbert gel on natural (Upper) and drug-protected (Lower) segments
of double helical DNA.
polymerase I (20). A second enzymatic digest with restriction
endonuclease Rsa I yielded two end-labeled fragments of 167-
and 516-nucleotide lengths. These were isolated by gel elec-
trophoresis on a 5% polyacrylamide, 1: 30 crosslinked, 4-mm-
thick preparatory gel. Further recovery and purification pro-
cedures were similar to those of Maxam and Gilbert (20).
Sequence Determination Gels. Resolution of inhibition pat-
terns was achieved by electrophoresis on 0.4-mm-thick, 40-cm-
long, 8% polyacrylamide 1:20 crosslinked sequence determi-
nation gels containing 50% urea. Electrophoresis was carried
out at 1,000 V for 3.5 hr to determine the sequence of 103 nu-
cleotides, beginning 25 nucleotides from the labeled 3' end.
Autoradiography was carried out at -500C without the use of
intensification screens.
Densitometry. A 20 X 25 cm copy of the original autoradi-
ogram was scanned at 500 nm with the incident beam collimated
to a width of 0.1 mm on a Cary 219 spectrophotometer. The
,data were recorded as-absorbance relative to the film base den-
sity and analyzed with an Apple microcomputer.
RESULTS
For an investigation of sequence-specific inhibition of DNA
strand cleavage by the antibiotics daunomycin, actinomycin D,
distamycin A, and netropsin, a naturally occurring DNA sub-
strate of known sequence was prepared. A 516-base-pair Rsa
I-EcoRI restriction fragment from the plasmid pBR322 (nu-
cleotides 3847-4363) was chosen. The EcoRI site was 3' end-
labeled with 32p. MPE-Fe(II)/dithiothreitol was allowed to
react with the 516-base-pair fragment alone and with the 516-
base-pair fragment preequilibrated with each of the four inhib-
iting drugs. Cleavage by MPE.Fe(II) was stopped after 10 min
by freezing, Iyophilization, and resuspension in a formamide
buffer. The end-labeled [32P]DNA products were analyzed by
denaturing 8% polyacrylamide/50% urea gel electrophoresis
capable of resolving DNA fragments differing in length by one
nucleotide. The autoradiogram data is shown in Fig. 4.
Control. Two control experiments in the absence of inhib-
iting drugs were carried out. The first (Fig. 4, lane 18) was the
buffered intact DNA (100 ,uM in base pairs) in the presence of
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10 ,uM Fe(II) and 4 mM dithiothreitol-concentrations used
in all subsequent cleavage-inhibition reactions. The 516-nu-
cleotide-long DNA remained intact, although trace quantities
of nicked DNA could be seen that later were shown to result
from nonspecific endonuclease activity. The two bands at the
top of control lane 18 are presumably the result of incomplete
denaturation ofthe 516-base-pair fragment. The second control
(Fig. 4, lane 17) depicted the relatively uniform cleavage pattern
generated by MPE (10 pM) in the presence of Fe(II) (10 ,uM)
and dithiothreitol (4 mM). This provided the baseline by which
other cleavage patterns were then compared. We found it con-
venient to analyze the data by densitometry (Fig. 5, lane 17).
Daunomycin. No pattern was observed with daunomycin in-
hibition of MPE-Fe(II) cleavage. Samples with increasing con-
centrations of daunomycin (Fig. 4, lanes 16-14) were allowed
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to incubate with the 516-base-pair DNA fragment. Treatment
with MPE-Fe(II)/dithiothreitol afforded a uniform cleavage
pattern not too different from that of the MPE-Fe(II) control
lane. Increasing amounts ofdaunomycin increased the average
length of the cleaved DNA fragment. The highest daunomycin
concentration is shown in lane 14, where much ofthe 516-base-
pair fragment remained intact.
Actinomycin D. Actinomycin D provided the first evidence
for the feasibility of the MPE.Fe(II) inhibition pattern proce-
dure. A series of bands or regions of alternating high and low
density on the autoradiogram were observed when MPE-Fe(II)/
dithiothreitol cleaved DNA in the presence ofactinomycin (Fig.
4, lanes 13-11). The highest concentration of actinomycin D
showed the sharpest inhibition patterns (lane 11). The regions
of low density, which indicate reduced cleavage by MPE.Fe(II),
appeared to be 4-16 nucleotides in length and centered around
at least one or more G-C base pairs. The densitometer trace
(Fig. 5, lane 11) allowed a measure of the actinomycin blocking
of MPE.Fe(II) DNA cleavage on a 103-nucleotide section ofthe
516-base-pair restriction fragment, illustrated as protected re-
gions on the sequence in Fig. 6, lane 11.
Distamycin A. Lower concentrations of distamycin A were
sufficient to produce well-resolved inhibition patterns com-
pared to the case of actinomycin D. Certain A+T-rich regions
that suffered efficient MPE.Fe(II) cleavage in the presence of
actinomycin were protected by distamycin (Fig. 4, light regions
on gel lanes 10-8). Inspection ofgel lanes 10 and 11 (distamycin
and actinomycin, respectively) reveals complementary regions
(G+C vs. A+T rich) resulting from different protection by the
two drugs (9). We were able to observe the effect of increasing
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FIG. 4. Autoradiogram of Maxam-Gilbert sequence determina-
tion gels. Lanes: 1-4, C+T, C, A>C, and Greactions, respectively (12);
5-18, reactions with 100 pM DNA, 10 pM Fe(ll), and 4 mM dithio-
threitol; 5-17, reactions with an inhibition drug and 10 ptM MPE; 5-7,
reactions with netropsin at 230 uM, 23 ,uM, and 2.3 pM, respectively;
8-10, reactions with distamycin A at 310 pM, 31 1M, and 3.1 p.M, re-
spectively; 11-13, reactions with actinomycin D at 325 pM, 32.5 PM,
and 3.25 pM, respectively; 14-16, reactions with daunomycin at 150
pM, 15 ,uM, and 1.5 uM, respectively; 17, reaction with MPE-Fe(ll)
with no inhibition drug; and 18, reaction with Fe(II) and no MPE or
inhibition drug.
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FIG. 5. Densitometer scan left to right corresponds to the bottom
to middle of the gel autoradiogram in Fig. 4, lanes 9, 10, 11, and 17.
Valleys are drug-protected regions from MPE-Fe(II) cleavage.
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concentration on site selection by distamycin A. At low dista-
mycin concentrations, we observed a series of inhibition gaps
:4-16 nucleotides in length-regions rich in A-T base pairs
with unprotected spacer regions between them (see Fig. 6, lane
10). As the distamycin concentration was increased, the flanking
spacer regions rich in A+T coalesced into one long A+T-rich
protected region (lane 11). However, certain sequences con-
taining four or more contiguous GC base pairs remained un-
protected even at the highest concentrations of distamycin.
Netropsin. Netropsin, a basic oligopeptide similar in struc-
ture to distamycin A, appeared to show the identical inhibition
patterns of distamycin A (Fig. 4, lanes 7-5). Not only were the
locations and lengths of the various protected regions duplicat-
ed, but also the identical coalescence of protected A+T-rich
regions at increasing concentrations ofnetropsin was observed.
DISCUSSION
Cleavage Reactions by MPE-Fe(II). MPE.Fe(II) was de-
signed and constructed as a non-sequence-specific model ofthe
antitumor antibiotic bleomycin (23, 24). Bleomycin cleaves
DNA in a reaction that is dependent on ferrous ion and 02 at
specific sequences (25, 26). The sequence-specific cleavage by
bleomycin rules out its effectiveness in generating DNA cleav-
age-inhibition patterns for small molecules. MPE has low se-
quence specificity not unexpected from the choice of methi-
dium, an intercalator oflow overall base composition specificity
(1, 27-29). However, a preference for binding to (3'-5')pyrimi-
dine-purine sequence compared to (3'-5')purine-pyrimidine in
deoxyribooligonucleotides has been established for ethidium
(30), as well as a preference for certain conformations of double
helical DNA (31).
Addition ofreducing agents such as dithiothreitol to solutions
of MPE-Fe(II) and DNA enhance the efficiency of the cleavage
reaction by 2 orders ofmagnitude (4). For optimum DNA cleav-
age-inhibition patterns, we found that fresh dithiothreitol at a
concentration in the millimolar range was best. MPE.Fe(II)/
base pair ratios were kept in the range of 1: 5 to 1: 20. Lower
concentrations of MPE produced insufficient DNA cleavage,
and higher concentrations afforded average DNA lengths too
small to provide a satisfactory set of patterns. A MPE.Fe(II)/
base pair ratio of 1:10 gave optimal results for the studies de-
scribed here. Like DNase inhibition patterns, MPE.Fe(II)
cleavage of drug-protected restriction fragments is a partial di-
gest, and there is the implicit assumption that a few MPE-Fe(II)
strand scissions on the 516-base-pair DNA fragment do not alter
the sequence specificity of the inhibiting drug.
The electrophoretic mobilities of fragments generated by
MPE.Fe(II) cleavage of 3T-labeled [32P]DNA, in the presence
or absence of inhibiting drugs, appeared equivalent to those
generated by conventional Maxam-Gilbert sequence deter-
mination procedures. This implies that the 5' terminus gen-
erated by MPE.Fe(II) cleavage is most likely a phosphate group
and that, under the denaturing conditions in the sequence assay
electrophoresis, the inhibiting drugs are not bound to the DNA.
We presume that the reaction responsible for DNA strand scis-
sion by MPE.Fe(II) is oxidative cleavage ofthe deoxyribose ring
analogous to mechanisms postulated for bleomycin activity
(23-24).
Choice of Inhibiting Drugs. Three of the inhibiting drugs
chosen for this test study of MPE-Fe(II) inhibition patterns
were known to have sequence preferences, binding site sizes
greater than two base pairs, and relatively slow dissociation
rates from DNA (1). We do not know yet the importance of size
and dissociation rate with regard to the inhibiting drug. For
example, although the inability of daunomycin to generate a
DNA cleavage-inhibition pattern could be due to a lack of base
composition specificity, an alternative explanation is that the
binding site size or dissociation rate may be not in a suitable
range to provide site-specific protection from MPE Fe(II) cleav-
age. Further work must be done to determine the scope and
limitations of the MPE inhibition pattern method.
Interpretation of the DNA Cleavage-Inhibition Pattern. In
principle, an altered DNA cleavage pattern could be the result
of suppressed reaction at some sites, enhanced reaction at oth-
ers, or a combination of both effects. Without ruling out the
possibility of enhanced cleavage, we have interpreted the light
regions on the autoradiogram as regions of reduced cleavage of
DNA by MPE'Fe(II) due to the presence of bound drug. The
light regions on the autoradiogram (Fig. 4) correspond to the
valleys in the densitometer tracings (Fig. 5), which in turn cor-
respond to the black regions on the 103-base-pair sequence
shown in Fig. 6.
We are not yet certain whether there is a one-to-one cor-
respondence of the protected region on one strand ofthe DNA
fragment and the drug binding site. The different accessibility
ofadjacent deoxyribose rings to the propyl-EDTA-Fe(II) moiety
in the unprotected site bound by methidium might result
in assymetric cleavage-inhibition patterns on opposite DNA
strands. Most likely the inhibition pattern on each DNA strand
is shifted by at least one base pair to the 3' 32P-labeled side of
the drug binding site.
CONCLUSION
The results reported here indicate the feasibility ofdetermining
the sequence specificity of DNA-binding small molecules on
heterogeneous double helical DNA by means of inhibition pat-
terns with DNA-cleaving agent MPEFe(II). Antibiotics such
as actinomycin D, distamycin A, and netropsin but not dau-
nomycin were observed to generate DNA cleavage-inhibition
patterns. These patterns have been sequenced, allowing the
location of preferred binding sites of three well-known anti-
biotics on naturally occurring DNA to be identified. Greater
precision in identifying the boundaries ofthe preferred binding
sites will be afforded by an opposite strand analysis (32). Dis-
tamycin A and netropsin gave identical results and bound pref-
erentially to A+T-rich regions with a minimal protected site of
four base pairs. Coalesence phenomena of certain spacer re-
gions were observed with these minor groove binders at high
concentrations. Actinomycin D afforded a completely different
inhibition pattern that was 4-16 base pairs long with protected
regions centered around one or more G-C base pairs.
With regard to implications for future studies, MPE-Fe(II)
LANE
-~~
____
_
9
_ W _ w _ S w - 1 II
5'CCTCGTGATACGCCTATTTT TaTAGGTTAATGTCATGATAATAATGGTTTCTTAGACGTCAGGTGGCACTTTTCGGGGAAATGTGCGCGGAACCCCTATTTGT
-VGACACTATCGATAAAAATATCCAATTACTCTTTATTACCAAAGAATCTGCAGTCCACCGTGAAAAGCCCCTTTACAGCGTTGGATAAACA
FIG. 6. Illustration of drug-protected regions (black areas) from MPE-Fe(II) cleavage on 103 base pairs of the lower strand of the 516-base-pair
fragment. The sequence from left to right corresponds to the bottom to middle of the gel autoradiogram in Fig. 4, lane 11 (actinomycin D at 325jM) and lanes 10 and 9 (distamycin A at 3.1 and 31 ,uM, respectively).
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inhibition patterns constitute a rapid technique for assaying
hundreds of potential DNA binding sites for antibiotics on one
gel. This direct method should prove useful for identifying the
preferred sites of DNA-binding small molecules on the native
nucleic acid template, which will be necessary for any under-
standing of the molecular basis of antibiotic action.
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